These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23275345)

  • 1. Autosomal recessive atrial dilated cardiomyopathy with standstill evolution associated with mutation of Natriuretic Peptide Precursor A.
    Disertori M; Quintarelli S; Grasso M; Pilotto A; Narula N; Favalli V; Canclini C; Diegoli M; Mazzola S; Marini M; Del Greco M; Bonmassari R; Masè M; Ravelli F; Specchia C; Arbustini E
    Circ Cardiovasc Genet; 2013 Feb; 6(1):27-36. PubMed ID: 23275345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac Emerinopathy: A Nonsyndromic Nuclear Envelopathy With Increased Risk of Thromboembolic Stroke Due to Progressive Atrial Standstill and Left Ventricular Noncompaction.
    Ishikawa T; Mishima H; Barc J; Takahashi MP; Hirono K; Terada S; Kowase S; Sato T; Mukai Y; Yui Y; Ohkubo K; Kimoto H; Watanabe H; Hata Y; Aiba T; Ohno S; Chishaki A; Shimizu W; Horie M; Ichida F; Nogami A; Yoshiura KI; Schott JJ; Makita N
    Circ Arrhythm Electrophysiol; 2020 Oct; 13(10):e008712. PubMed ID: 32755394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial cardiomyopathy an orphan disease or common disorder?
    Fatkin D; Nikolova-Krstevski V
    Circ Cardiovasc Genet; 2013 Feb; 6(1):5-6. PubMed ID: 23424254
    [No Abstract]   [Full Text] [Related]  

  • 4. Ventricular expression of atrial and brain natriuretic peptides in dilated cardiomyopathy. An immunohistocytochemical study of the endomyocardial biopsy specimens using specific monoclonal antibodies.
    Hasegawa K; Fujiwara H; Doyama K; Mukoyama M; Nakao K; Fujiwara T; Imura H; Kawai C
    Am J Pathol; 1993 Jan; 142(1):107-16. PubMed ID: 8424448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial atrial standstill in association with dilated cardiomyopathy.
    Fazelifar AF; Arya A; Haghjoo M; Sadr-Ameli MA
    Pacing Clin Electrophysiol; 2005 Sep; 28(9):1005-8. PubMed ID: 16176547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding spectrum of human RYR2-related disease: new electrocardiographic, structural, and genetic features.
    Bhuiyan ZA; van den Berg MP; van Tintelen JP; Bink-Boelkens MT; Wiesfeld AC; Alders M; Postma AV; van Langen I; Mannens MM; Wilde AA
    Circulation; 2007 Oct; 116(14):1569-76. PubMed ID: 17875969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease.
    Fatkin D; MacRae C; Sasaki T; Wolff MR; Porcu M; Frenneaux M; Atherton J; Vidaillet HJ; Spudich S; De Girolami U; Seidman JG; Seidman C; Muntoni F; Müehle G; Johnson W; McDonough B
    N Engl J Med; 1999 Dec; 341(23):1715-24. PubMed ID: 10580070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated left atrial standstill identified during catheter ablation.
    Duncan E; Schilling RJ; Earley M
    Pacing Clin Electrophysiol; 2013 Apr; 36(4):e120-4. PubMed ID: 21070263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compound heterozygous mutations in the SCN5A-encoded Nav1.5 cardiac sodium channel resulting in atrial standstill and His-Purkinje system disease.
    Baskar S; Ackerman MJ; Clements D; Mayuga KA; Aziz PF
    J Pediatr; 2014 Nov; 165(5):1050-2. PubMed ID: 25171853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High incidence of sudden cardiac death with conduction disturbances and atrial cardiomyopathy caused by a nonsense mutation in the STA gene.
    Sakata K; Shimizu M; Ino H; Yamaguchi M; Terai H; Fujino N; Hayashi K; Kaneda T; Inoue M; Oda Y; Fujita T; Kaku B; Kanaya H; Mabuchi H
    Circulation; 2005 Jun; 111(25):3352-8. PubMed ID: 15967842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamin A/C mutation is independently associated with an increased risk of arterial and venous thromboembolic complications.
    van Rijsingen IA; Bakker A; Azim D; Hermans-van Ast JF; van der Kooi AJ; van Tintelen JP; van den Berg MP; Christiaans I; Lekanne Dit Deprez RH; Wilde AA; Zwinderman AH; Meijers JC; Grootemaat AE; Nieuwland R; Pinto YM; Pinto-Sietsma SJ
    Int J Cardiol; 2013 Sep; 168(1):472-7. PubMed ID: 23073275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
    Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome and risk stratification in dilated cardiolaminopathies.
    Pasotti M; Klersy C; Pilotto A; Marziliano N; Rapezzi C; Serio A; Mannarino S; Gambarin F; Favalli V; Grasso M; Agozzino M; Campana C; Gavazzi A; Febo O; Marini M; Landolina M; Mortara A; Piccolo G; Viganò M; Tavazzi L; Arbustini E
    J Am Coll Cardiol; 2008 Oct; 52(15):1250-60. PubMed ID: 18926329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel TBX5 loss-of-function mutation associated with sporadic dilated cardiomyopathy.
    Zhou W; Zhao L; Jiang JQ; Jiang WF; Yang YQ; Qiu XB
    Int J Mol Med; 2015 Jul; 36(1):282-8. PubMed ID: 25963046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in natriuretic peptides following passive containment surgery in heart failure patients with dilated cardiomyopathy.
    Bredin F; Liska J; Franco-Cereceda A
    Interact Cardiovasc Thorac Surg; 2009 Feb; 8(2):191-4. PubMed ID: 19008326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential localization of atrial natriuretic peptide and skeletal alpha-actin messenger RNAs in left ventricular myocytes of patients with dilated cardiomyopathy.
    Tanaka M; Hiroe M; Ito H; Nishikawa T; Adachi S; Aonuma K; Marumo F
    J Am Coll Cardiol; 1995 Jul; 26(1):85-92. PubMed ID: 7797780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel lamin A/C mutations in two families with dilated cardiomyopathy and conduction system disease.
    Jakobs PM; Hanson EL; Crispell KA; Toy W; Keegan H; Schilling K; Icenogle TB; Litt M; Hershberger RE
    J Card Fail; 2001 Sep; 7(3):249-56. PubMed ID: 11561226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac voltage-gated sodium channel mutations associated with left atrial dysfunction and stroke in children.
    Moreau A; Janin A; Millat G; Chevalier P
    Europace; 2018 Oct; 20(10):1692-1698. PubMed ID: 29579189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial natriuretic peptide gene polymorphism is not associated with hypertrophic cardiomyopathy.
    Xue H; Wang H; Wang XJ; Sun K; Wang SX; Song XD; Hui RT
    Chin Med J (Engl); 2010 Jan; 123(2):188-92. PubMed ID: 20137368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the C-type natriuretic peptide have prognostic value in chagas disease and other dilated cardiomyopathies?
    Heringer-Walther S; Moreira Mda C; Wessel N; Wang Y; Ventura TM; Schultheiss HP; Walther T
    J Cardiovasc Pharmacol; 2006 Dec; 48(6):293-8. PubMed ID: 17204908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.